Spatial Disparities in Mifepristone Use for Early Miscarriage and Induced Abortion Among Obstetrician–Gynecologists Practicing in Massachusetts

Background: About 25% of pregnancies end in early miscarriage or abortion annually in the United States. While mifepristone is part of the most effective medication regimen for miscarriage and abortion, regulatory burdens and legal restrictions limit its provision in obstetric–gynecological practice...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily Newton-Hoe, Alisa B. Goldberg, Jennifer Fortin, Elizabeth Janiak, Sara Neill
Format: Article
Language:English
Published: Mary Ann Liebert 2024-04-01
Series:Women's Health Reports
Subjects:
Online Access:https://www.liebertpub.com/doi/10.1089/whr.2024.0085
Tags: Add Tag
No Tags, Be the first to tag this record!